Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysis.
O'Leary C, Greer R, Huggett G, Good P, Gurgenci T, Hardy J.
O'Leary C, et al. Among authors: good p.
BMJ Support Palliat Care. 2024 May 17;14(2):191-194. doi: 10.1136/spcare-2023-004746.
BMJ Support Palliat Care. 2024.
PMID: 38307703
Clinical Trial.
No significant difference in disease progression was noted between the two groups at days 14 (p=0.33), 28 (p=0.67) or 56 (p=0.50). There was no difference in survival between both groups from study entry to censor date (p=0.38). Disease progression at …
No significant difference in disease progression was noted between the two groups at days 14 (p=0.33), 28 (p=0.67) or 56 (p …